首页 | 本学科首页   官方微博 | 高级检索  
     

胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义
引用本文:李凯,赵卫星,鲍永华,杨万才. 胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义[J]. 中华诊断学电子杂志, 2016, 4(1): 45-47. DOI: 10.3877/cma.j.issn.2095-655X.2016.01.013
作者姓名:李凯  赵卫星  鲍永华  杨万才
作者单位:1. 453100 新乡医学院第一附属医院病理科2. 453003 新乡医学院基础医学院免疫学教研室3. 453003 新乡医学院基础医学院病理教研室
基金项目:国家自然科学基金(91229115)
摘    要:
目的探讨人丝氨酸蛋白酶8(PRSS8)在胃炎、食管炎和食管癌患者血清中的表达情况及意义。 方法采集临床诊断为食管炎、食管癌和胃炎患者以及正常人群的血清样本,其中食管炎患者血清样本20例,食管癌患者血清样本6例,胃炎患者血清样本60例,正常血清样本28例。采用酶联免疫吸附法(ELISA)的方法测定各组中PRSS8的表达水平,并将食管炎患者组、食管癌患者组和胃炎患者组分别与正常组相比较。 结果各组血清PRSS8表达水平差异有统计学意义(F=13.24,P<0.01)。食管炎患者组PRSS8表达水平[(4.58±1.67)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=2.59,P<0.05);食管癌患者组PRSS8表达水平[(5.05±0.57)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=2.54,P<0.05);食管癌患者组PRSS8表达水平[(5.05±0.57)μg/L]高于食管炎患者组[(4.58±1.67)μg/L],差异无统计学意义(LSD-t=0.83,P>0.05);胃炎患者组PRSS8表达水平[(5.39±1.04)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=6.22,P<0.05)。 结论食管炎、食管癌和胃炎患者血清中PRSS8表达水平均增高,提示血清中的PRSS8可能与食管炎、食管癌和胃炎的发生发展相关。

关 键 词:食管炎  食管肿瘤  胃炎  丝氨酸蛋白酶类  血清  
收稿时间:2015-12-03

The serum levels of PRSS8 and their clinical significance in the patients with gastritis,esophagitis and esophageal cancer
Kai Li,Weixing Zhao,Yonghua Bao,Wancai Yang. The serum levels of PRSS8 and their clinical significance in the patients with gastritis,esophagitis and esophageal cancer[J]. Chinese Journal of Diagnostics (Electronic Edition), 2016, 4(1): 45-47. DOI: 10.3877/cma.j.issn.2095-655X.2016.01.013
Authors:Kai Li  Weixing Zhao  Yonghua Bao  Wancai Yang
Affiliation:1. Department of Pathology, the First Affiliated Hospital of Xinxiang Medical University, Weihui 4531002. Department of Immunology, Xinxiang Medical University, Xinxiang 453003, China3. Department of Pathology, Xinxiang Medical University, Xinxiang 453003, China
Abstract:
ObjectiveTo study the expression level and significance of serum human protease serine 8(PRSS8) in the patient with gastritis, esophagitis and esophageal cancer. MethodsThe serum samples from healthy subjects and the patients diagnosed as esophagitis, esophageal cancer and gastritis were collected.The serum samples included 20 esophagitis serum samples, 6 esophageal cancer serum samples, 60 gastritis serum samples and 28 healthy serum samples.The expression level of PRSS8 was detected by ELISA assay.Then the serum PRSS8 levels from the esophagitis group, esophageal cancer group and the gastritis group were compared with the healthy group, respectively. ResultsThe serum level of PRSS8 in esophagitis group [(4.58±1.67)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was statistically significant(LSD-t=2.59, P<0.05). The serum level of PRSS8 in esophageal cancer group [(5.05±0.57)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was statistically significant(LSD-t=2.54, P<0.05). The serum level of PRSS8 in esophageal cancer group [(5.05±0.57)μg/L] was higher than that from the esophagitis group [(4.58±1.67)μg/L], the difference was not statistically significant(LSD-t=0.83, P>0.05). The level of serum PRSS8 in gastritis group [(5.39±1.04)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was also statistically significant (LSD-t=6.22, P<0.05). ConclusionSerum PRSS8 expression levels are obviously increased in the patients with esophagitis, esophageal cancer and gastritis, which suggests that serum PRRS8 maybe relate to the development of esophagitis, esophageal cancer and gastritis.
Keywords:Esophagitis  Esophageal neoplasms  Gastritis  Serine proteases  Serum  
点击此处可从《中华诊断学电子杂志》浏览原始摘要信息
点击此处可从《中华诊断学电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号